23andMe Provides Update Regarding Court-Supervised Sale Proc...

Coherent Introduces Axon FL: a Versatile Fiber Coupling Module for Mini2P Applications SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a leading human genetics and biotechnology company, today provided additional information on the protections in place for customer data in connection with the court-supervised sale of the Company's assets. The process is being led by the Special Committee of the Company's Board of Directors, which will evaluate potential acquisition bids, and supervised by the U.S. Bankruptcy Court for the Eastern District of Missouri (the "Court"), an independent third party who must review and approve any transaction. Regulatory Review A key factor in the consideration of qualified bids will be a potential bidder's ability to consummate a transaction and pass required regulatory reviews expeditiously, i...